Phase II trial of induction chemotherapy followed by surgery for squamous cell carcinoma of the oral tongue in young adults

Head and Neck

Volumn 34, Issue 9, 2012, Pages 1255-1262

  Kies, Merrill S ^a   Boatright, Dowin H ^a,b   Li, Guojun ^a   Blumenschein, George ^a   El Naggar, Adel K ^a   Brandon Gunn, G ^a   Lewin, Jan S ^a   Steinhaus, Ganene D ^a   Sturgis, Erich M ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

induction chemotherapy; oral tongue cancer; young adults

Indexed keywords

CARBOPLATIN; IFOSFAMIDE; PACLITAXEL;

ADULT; ADVERSE OUTCOME; ALOPECIA; ANEMIA; ANOREXIA; ARTICLE; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CLINICAL ARTICLE; CONSTIPATION; CONTROLLED STUDY; DEHYDRATION; DISEASE FREE SURVIVAL; DISEASE SPECIFIC SURVIVAL; DIZZINESS; FATIGUE; FEBRILE NEUTROPENIA; FEMALE; FOLLOW UP; GASTROINTESTINAL DISEASE; GLOSSECTOMY; GRANULOCYTOPENIA; HEMATURIA; HISTOPATHOLOGY; HUMAN; INDUCTION CHEMOTHERAPY; INFECTION; INSOMNIA; LEUKOPENIA; LUNG METASTASIS; MALE; MOUTH SQUAMOUS CELL CARCINOMA; MYALGIA; NAUSEA; NECK DISSECTION; OVERALL SURVIVAL; PAIN; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RASH; SIDE EFFECT; SQUAMOUS CELL CARCINOMA; SQUAMOUS CELL CARCINOMA OF THE ORAL TONGUE; STOMATITIS; THROMBOCYTOPENIA; THROMBOPHLEBITIS; TISSUE DIFFERENTIATION; TONGUE CARCINOMA; TREATMENT RESPONSE; VOMITING; WEIGHT REDUCTION;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; GLOSSECTOMY; HUMANS; IFOSFAMIDE; INDUCTION CHEMOTHERAPY; MALE; MIDDLE AGED; NECK DISSECTION; NEOPLASMS, SQUAMOUS CELL; PACLITAXEL; PROGNOSIS; SURVIVAL ANALYSIS; TONGUE NEOPLASMS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84865011437     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21906     Document Type: Article

References (12)

1. Jemal A, Siegel R, Xu J, Ward E,. Cancer Statistics, 2010. CA Cancer J Clin 2010; 60: 277-300.
2. Shiboski CH, Schmidt BL, Jordan RC,. Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20-44 years. Cancer 2005; 103: 1843-1849. (Pubitemid 40563256)
3. Bernier J, Domenge C, Ozsahin C, et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 2004; 350: 1945-1952. (Pubitemid 38580197)
4. Cooper JS, Pajak TF, Forastiere AA, et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 2004; 350: 1937-1944.
5. Carvalho AL, Nishimoto IN, Califano JA, Kowalski LP,. Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database. Int J Cancer 2005; 114: 806-808.
6. Sturgis EM, Moore BA, Glisson BS, Kies MS, Shin DM, Byers RM,. Neoadjuvant chemotherapy for the young adult with squamous cell carcinoma of the oral tongue: a case series. Head Neck 2005; 27: 748-756. (Pubitemid 41266178)
7. Barringer DA, Hutcheson KA, Sturgis EM, Kies MS, Lewin JS,. Effect of induction chemotherapy on speech and swallowing function in patients with oral tongue cancer. Head Neck 2009; 31: 611-617.
8. Shin DM, Glisson BS, Khuri FR, et al. Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck. Cancer 2002; 95: 322-330. (Pubitemid 34787599)
9. Holsinger FC, Kies MS, Diaz EM Jr, et al. Durable long-term remission with chemotherapy alone for stage II to IV laryngeal cancer. J Clin Oncol 2009; 27: 1976-1982.
10. Furness S, Glenny AM, Worthington HV, et al. Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy. Cochrane Database of Systematic Reviews 2010, issue 9.
11. Licitra L, Grandi C, Guzzo M, et al. Primary chemotherapy in resectable oral cavity squamous cell carcinoma: a randomized controlled trial. J Clin Oncol 2003; 21: 327-333. (Pubitemid 46606163)
12. Perrone F, Bossi P, Cortelazzi B, et al. TP53 mutations and pathologic complete response to neoadjuvant cisplatin and fluorouracil chemotherapy in resected oral cavity squamous cell carcinoma. J Clin Oncol 2010; 28: 761-766.